{"nct_id":"NCT02161575","title":"Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD","status":"COMPLETED","status_verified_date":"2019-02","start_date":"2014-08-28","start_date_type":"ACTUAL","primary_completion_date":"2017-09-14","primary_completion_date_type":"ACTUAL","completion_date":"2017-09-14","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVS"]}